Prospective cohort study of pediatric acute lymphoblastic leukemia patients treated with Tokyo Children's Cancer Study Group risk stratification TCCSG ALL L09-1603.version1.1

Prospective cohort study of pediatric acute lymphoblastic leukemia patients treated with Tokyo Children's Cancer Study Group risk stratification TCCSG ALL L09-1603.version1.1 - Prospective cohort study of pediatric ALL treated with TCCSG risk stratification TCCSG ALL L09-1603 v1.1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003375

Enrollment

400

Registered

2010-03-26

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: previously untreated pediatric ALL patients age between 1 and 18years. Written informed consent to participate this observational study

Exclusion criteria

Exclusion criteria: secondary leukemia previously treated patients

Design outcomes

Primary

Measure	Time frame
5y event free survival 5y overall survival	—

Secondary

Measure	Time frame
The frequency of therapy toxicity	—

Countries

Japan

Contacts

Public ContactAkira Ohara

Toho University Omori Hospital, Dep. of Transfusion

aohara@med.toho-u.ac.jp81337624151

Outcome results